Company / PP&E (Net)
LifeStance Health Group, Inc. PP&E (Net) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$161.6M
FY2025
5-year range
$152.2M / $194.2M
FY2021-FY2025
Trend
-2.7%
vs FY2024
Sector context
#72 of 135
Health Care
What the data says
At $162M, LifeStance Health Group, Inc.'s pp&e (net) ranks #72 of 135 in the Health Care sector. PP&E (Net) has declined for 3 consecutive years, from $194M in FY2022 to $162M in FY2025.
Based on SEC 10-K filings.
$162M in FY2025 with a 5-year CAGR of +22.2%.
Declined from $188M to $162M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -5.9%
- 5-Year CAGR
- +22.2%
- 10-Year CAGR
- -
Sector benchmark
#72 of 135 in Health CareTop 53% of 135This company $161.6M Sector average $1.4B
▼
-88.1% below sector average
Key checks
Key Insights
- LifeStance Health Group, Inc.'s pp&e (net) has declined for 3 consecutive years.
- 5-year CAGR of +22.2%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 2.7% year-over-year.
- Ranks #72 out of 135 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $161.6M | -2.7% |
| FY2024 | $166.0M | -11.8% |
| FY2023 | $188.2M | -3.1% |
| FY2022 | $194.2M | +27.6% |
| FY2021 | $152.2M | +156.5% |
| FY2020 | $59.3M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026